ConcertAI
Provides real-world data and AI software solutions for oncology clinical development.
What they do
ConcertAI provides real-world data, AI technologies, and advanced analytics software for oncology and life sciences. The company partners with healthcare providers and pharmaceutical companies to accelerate clinical trials, generate real-world evidence, and improve patient outcomes through precise data insights.
The record
- Vertical
- Oncology
- Sub-segment
- Real-world data and analytics
- Product type
- Platform software
- Stage
- Growth
- Headquarters
- Cambridge, United States
- Region
- North America
- Founded
- 2017
- Total funding
- $300M raised
Notable investors: Romulus Capital, Declaration Partners, SymphonyAI Group.